Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors
Author
dc.contributor.author
Lobos González, Lorena
Author
dc.contributor.author
Silva, Verónica
Author
dc.contributor.author
Araya, Mariela
Author
dc.contributor.author
Restovic, Franko
Author
dc.contributor.author
Echeñique, Javiera
Author
dc.contributor.author
Oliveira Cruz, Luciana
Author
dc.contributor.author
Fitzpatrick, Christopher
Author
dc.contributor.author
Briones, Macarena
Author
dc.contributor.author
Villegas, Jaime
Author
dc.contributor.author
Villota, Claudio
Author
dc.contributor.author
Vidaurre, Soledad
Author
dc.contributor.author
Borgna, Vincenzo
Author
dc.contributor.author
Socias, Miguel
Author
dc.contributor.author
Valenzuela, Sebastián
Author
dc.contributor.author
López, Constanza
Author
dc.contributor.author
Socias, Teresa
Author
dc.contributor.author
Varas, Manuel
Author
dc.contributor.author
Díaz, Jorge
Author
dc.contributor.author
Burzio, Luis O.
Author
dc.contributor.author
Burzio, Verónica A.
Admission date
dc.date.accessioned
2017-11-21T15:07:58Z
Available date
dc.date.available
2017-11-21T15:07:58Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Oncotarget, Vol. 7, No. 36 Sept 2016
es_ES
Identifier
dc.identifier.other
10.18632/oncotarget.11110
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/145708
Abstract
dc.description.abstract
We reported that knockdown of the antisense noncoding mitochondrial RNAs (ASncmtRNAs) induces apoptotic death of several human tumor cell lines, but not normal cells, suggesting this approach for selective therapy against different types of cancer. In order to translate these results to a preclinical scenario, we characterized the murine noncoding mitochondrial RNAs (ncmtRNAs) and performed in vivo knockdown in syngeneic murine melanoma models. Mouse ncmtRNAs display structures similar to the human counterparts, including long double-stranded regions arising from the presence of inverted repeats. Knockdown of ASncmtRNAs with specific antisense oligonucleotides (ASO) reduces murine melanoma B16F10 cell proliferation and induces apoptosis in vitro through downregulation of pro-survival and metastasis markers, particularly survivin. For in vivo studies, subcutaneous B16F10 melanoma tumors in C57BL/6 mice were treated systemically with specific and control antisense oligonucleotides (ASO). For metastasis studies, tumors were resected, followed by systemic administration of ASOs and the presence of metastatic nodules in lungs and liver was assessed. Treatment with specific ASO inhibited tumor growth and metastasis after primary tumor resection. In a metastasis-only assay, mice inoculated intravenously with cells and treated with the same ASO displayed reduced number and size of melanoma nodules in the lungs, compared to controls. Our results suggest that ASncmtRNAs could be potent targets for melanoma therapy. To our knowledge, the ASncmtRNAs are the first potential non-nuclear targets for melanoma therapy.